Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

196 ARTÍCULOS , VIENDO DEL 121 AL 135

Advancing medicine for Alzheimer's disease: A plasma neural exosome platform

Goetzl EJ.

FASEB J. 2020 Oct;34(10):13079-13084. doi: 10.1096/fj.202001655. Epub 2020 Aug 28.

Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis

Rezabakhsh A, Rahbarghazi R, Fathi F.

Biosens Bioelectron. 2020 Nov 1;167:112511. doi: 10.1016/j.bios.2020.112511. Epub 2020 Aug 17.

Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology

Mullins AE, Kam K, Parekh A, Bubu OM, Osorio RS, Varga AW.

Neurobiol Dis. 2020 Nov;145:105054. doi: 10.1016/j.nbd.2020.105054. Epub 2020 Aug 27.

Trying to get ahead of Alzheimer disease

Mandell BF.

Cleve Clin J Med. 2020 Aug 31;87(9):517-518. doi: 10.3949/ccjm.87b.09020.

Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease

Carapelle E, Mundi C, Cassano T, Avolio C.

Int J Mol Sci. 2020 Aug 30;21(17):6279. doi: 10.3390/ijms21176279.

[Epidemiology of Alzheimer's disease: latest trends]

Dumurgier J, Sabia S.

Rev Prat. 2020 Feb;70(2):149-151.

[Alzheimer's disease: a biological disorder?]

Hugon J.

Rev Prat. 2020 Feb;70(2):152-155.

[Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis)]

Ivanoiu A, Engelborghs S, Hanseeuw B.

Rev Prat. 2020 Feb;70(2):158-163.

Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer's Disease and the Blood-Brain Barrier

Semyachkina-Glushkovskaya O, Postnov D, Penzel T, Kurths J.

Int J Mol Sci. 2020 Aug 31;21(17):6293. doi: 10.3390/ijms21176293.

HLA in Alzheimer's Disease: Genetic Association and Possible Pathogenic Roles

Wang ZX, Wan Q, Xing A.

Neuromolecular Med. 2020 Dec;22(4):464-473. doi: 10.1007/s12017-020-08612-4. Epub 2020 Sep 7.

PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients

Wang HY, Pei Z, Lee KC, Lopez-Brignoni E, Nikolov B, Crowley CA, Marsman MR, Barbier R, Friedmann N, Burns LH.

J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.

A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group

O'Gorman C, Khoury R, Anderson A, Carter M, DiCesare F, Dubé S, Ereshefsky L, Grossberg G, Hefting N, Khan S, Lind S, Moebius H, Shiovitz T, Rosenberg P.

J Prev Alzheimers Dis. 2020;7(4):274-282. doi: 10.14283/jpad.2020.37.

Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research

Blazel MM, Lazar KK, Van Hulle CA, Ma Y, Cole A, Spalitta A, Davenport-Sis N, Bendlin BB, Wahoske M, Illingworth C, Gleason CE, Edwards DF, Blazel H, Asthana S, Johnson SC, Carlsson CM.

J Alzheimers Dis. 2020;77(4):1559-1567. doi: 10.3233/JAD-200394.

Protein Biomarkers for the Diagnosis of Alzheimer's Disease at Different Stages of Neurodegeneration

Pérez M, Hernández F, Avila J.

Int J Mol Sci. 2020 Sep 15;21(18):6749. doi: 10.3390/ijms21186749.

Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps

Badji A, Westman E.

Psychiatry Res Neuroimaging. 2020 Dec 30;306:111184. doi: 10.1016/j.pscychresns.2020.111184. Epub 2020 Sep 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias